Comparison of Two Strategies for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients.
2026-08-11, Transplant infectious disease : an official journal of the Transplantation Society (10.1111/tid.70297) (online)Sandra Rajme-López, Shaul Ariel Navarro-Lara, Juan José Calva-Mercado, Tomas Rafael Mercado-Torres, Mariana Vélez-Pintado, Bernardo Alfonso Martínez-Guerra, Carla Marina Román-Montes, Ever Arturo Corral-Herrera, Héctor Orlando Rivera-Villegas, Nayelli Cointa Flores-García, Luis Eduardo Morales-Buenrostro, María Fernanda González-Lara, and Karla María Tamez-Torres (?)
Cytomegalovirus (CMV) remains a major cause of morbidity in solid organ transplant (SOT) recipients. While universal prophylaxis and preemptive therapy (PET) are standard strategies, comparative data in Latin American populations-characterized by high CMV seroprevalence-are limited.
This article has not yet been included in any curations.



Comments
There are no comments on this article yet.
You need to login or register to comment.